NCT03252704

Brief Summary

This randomized, double-blind, comparator controlled trial evaluated the blood glucose and insulin responses in healthy adults, after consuming a high fiber or low fiber muffin top.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2016

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2016

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 17, 2017

Completed
Last Updated

August 21, 2017

Status Verified

August 1, 2017

Enrollment Period

7 months

First QC Date

August 14, 2017

Last Update Submit

August 16, 2017

Conditions

Keywords

postprandial glucose insulin

Outcome Measures

Primary Outcomes (1)

  • Blood glucose response

    IV and capillary

    0-4 hours after consumption

Secondary Outcomes (2)

  • Blood insulin response

    0-4 hours after consumption

  • Breath hydrogen response

    0-24 hours after consumption

Study Arms (2)

High fiber - low fiber

EXPERIMENTAL

Treatment order described in arm title, resistant starch (high fiber muffin top) - conventional flour (low fiber muffin top)

Other: resistant starch (high fiber muffin top)Other: control (low fiber muffin top)

low fiber - high fiber

EXPERIMENTAL

Treatment order described in arm title, conventional flour (low fiber muffin top)- resistant starch (high fiber muffin top)

Other: resistant starch (high fiber muffin top)Other: control (low fiber muffin top)

Interventions

Muffin top contained 11 g of fiber per portion

High fiber - low fiberlow fiber - high fiber

Muffin top contained 1 g of fiber per portion

High fiber - low fiberlow fiber - high fiber

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older,
  • BMI 18.0-29.9 kg/m2,
  • fasting glucose ≤ 6.0 mmol/L;
  • if female, not of childbearing potential (e.g. taking oral contraceptives, past hysterectomy)

You may not qualify if:

  • diagnosed metabolic or chronic diseases (e.g. type-2 diabetes);
  • cancer diagnosis or treatment within 5 years;
  • gastrointestinal problems;
  • bowel cleansing during prior week;
  • current medications to control blood glucose;
  • current medications to control blood cholesterol ;
  • current medications to control blood pressure;
  • smoker;
  • use of medical marijuana;
  • alcohol or drug abuse treatment in past 12 months;
  • allergy or sensitivity to study products;
  • blood donation in prior 2 months;
  • if female, currently pregnant, currently breastfeeding, or planning to become pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Stewart ML, Zimmer JP. Postprandial glucose and insulin response to a high-fiber muffin top containing resistant starch type 4 in healthy adults: a double-blind, randomized, controlled trial. Nutrition. 2018 Sep;53:59-63. doi: 10.1016/j.nut.2018.01.002. Epub 2018 Feb 13.

MeSH Terms

Interventions

Resistant Starch

Intervention Hierarchy (Ancestors)

StarchGlucansBiopolymersPolymersMacromolecular SubstancesDietary FiberDietary CarbohydratesCarbohydratesPolysaccharidesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Tetyana Pelipyagina, MD

    KGK Synergize

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Study products were concealed in opaque foil envelopes. The treatments were identified by alphanumeric code. The subjects and investigators did not know the identity of the treatments.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2017

First Posted

August 17, 2017

Study Start

March 31, 2016

Primary Completion

October 31, 2016

Study Completion

October 31, 2016

Last Updated

August 21, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share